Volgen
Rob Walker
Rob Walker
Geverifieerd e-mailadres voor umn.edu
Titel
Geciteerd door
Geciteerd door
Jaar
Association of testosterone therapy with risk of venous thromboembolism among men with and without hypogonadism
RF Walker, NA Zakai, RF MacLehose, LT Cowan, TJ Adam, A Alonso, ...
JAMA internal medicine 180 (2), 190-197, 2020
1352020
Branching and merging: an investigation into current version control practices
S Phillips, J Sillito, R Walker
Proceedings of the 4th International Workshop on Cooperative and Human …, 2011
802011
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: trends from 2012 to 2017
PL Lutsey, RF Walker, RF MacLehose, A Alonso, TJ Adam, NA Zakai
Research and practice in thrombosis and haemostasis 3 (4), 668-673, 2019
782019
Vagus nerve stimulation as a potential therapy in early Alzheimer’s disease: A review
M Vargas-Caballero, H Warming, R Walker, C Holmes, G Cruickshank, ...
Frontiers in human neuroscience 16, 866434, 2022
582022
Risk of hospitalised bleeding in comparisons of oral anticoagulant options for the primary treatment of venous thromboembolism
PL Lutsey, NA Zakai, RF MacLehose, FL Norby, RF Walker, NS Roetker, ...
British journal of haematology 185 (5), 903-911, 2019
382019
Impact of anticoagulant choice on hospitalized bleeding risk when treating cancer‐associated venous thromboembolism
NA Zakai, RF Walker, RF MacLehose, TJ Adam, A Alonso, PL Lutsey
Journal of Thrombosis and Haemostasis 16 (12), 2403-2412, 2018
262018
Venous thrombosis risk during and after medical and surgical hospitalizations: the medical inpatient thrombosis and hemostasis (MITH) study
XJ Bruno, I Koh, PL Lutsey, RF Walker, NS Roetker, K Wilkinson, ...
Journal of Thrombosis and Haemostasis 20 (7), 1645-1652, 2022
232022
Inpatient versus outpatient acute venous thromboembolism management: trends and postacute healthcare utilization from 2011 to 2018
PL Lutsey, RF Walker, RF MacLehose, FL Norby, LH Evensen, A Alonso, ...
Journal of the American Heart Association 10 (20), e020428, 2021
192021
Direct oral anticoagulants and warfarin for atrial fibrillation treatment: rural and urban trends in Medicare beneficiaries
FL Norby, PL Lutsey, ND Shippee, LY Chen, C Henning-Smith, A Alonso, ...
American Journal of Cardiovascular Drugs, 1-11, 2022
142022
Simulation verifies advantages of multiple fracs in horizontal well
RF Walker, E Ehrl, M Arasteh
Oil and Gas Journal;(United States) 91 (48), 1993
131993
Incidence and risk factors of pulmonary hypertension after venous thromboembolism: an analysis of a large health care database
PL Lutsey, LH Evensen, T Thenappan, KW Prins, RF Walker, JF Farley, ...
Journal of the American Heart Association 11 (14), e024358, 2022
122022
Venous thromboembolism mortality and trends in older US adults, 2011–2019
K Giorgio, RF Walker, RF MacLehose, D Adrianzen‐Herrera, W Wang, ...
American journal of hematology 98 (9), 1364-1373, 2023
92023
Effect of chronic digoxin use on mortality and heart failure hospitalization in pulmonary arterial hypertension
KY Chang, K Giorgio, K Schmitz, RF Walker, KW Prins, MR Pritzker, ...
Journal of the American Heart Association 12 (6), e027559, 2023
82023
Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism. JAMA Intern Med. 2019
RF Walker, NA Zakai, RF MacLehose, LT Cowan, TJ Adam, A Alonso
62019
Autoimmune disease and risk of postpartum venous thromboembolism
RF Walker, NA Zakai, SM Mason, RF MacLehose, FL Norby, LH Evensen, ...
Research and practice in thrombosis and haemostasis 7 (2), 100091, 2023
52023
SGLT2 inhibitors are associated with reduced cardiovascular disease in patients with type 2 diabetes: an analysis of real-world data
W Wang, LY Chen, RF Walker, LS Chow, FL Norby, A Alonso, JS Pankow, ...
Mayo Clinic Proceedings 98 (7), 985-996, 2023
42023
Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
NA Zakai, RF Walker, RF MacLehose, I Koh, A Alonso, PL Lutsey
Research and Practice in Thrombosis and Haemostasis 5 (6), e12575, 2021
42021
Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
RF MacLehose, NA Zakai, RF Walker, A Alonso, T Adams, PL Lutsey
Research and Practice in Thrombosis and Haemostasis 5 (4), e12514, 2021
42021
Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
D Adrianzen-Herrera, PL Lutsey, K Giorgio, RF Walker, NA Zakai
Research and Practice in Thrombosis and Haemostasis 7 (1), 100024, 2023
32023
Impact of oral anticoagulation choice on healthcare utilization for the primary treatment of venous thromboembolism
PL Lutsey, RF MacLehose, JNS Claxton, RF Walker, TJ Adam, A Alonso, ...
Vascular Medicine 25 (6), 549-556, 2020
32020
Het systeem kan de bewerking nu niet uitvoeren. Probeer het later opnieuw.
Artikelen 1–20